Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a specific protein signal can make hair grow on mouse nipples.

GLI2 increases follistatin production in human skin cells.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Suppressing certain hormones might help prevent prostate cancer.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

Tamoxifen caused hair loss in a 52-year-old woman.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Low zinc levels may be linked to the return of gynecologic cancers.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Using gelatin sponges for deep skin wounds helps bone marrow cells repair tissue without scarring.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Different types of skin cells play specific roles in development, healing, and cancer.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.